Cargando…

Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia

Humans infected with SARS-CoV-2 may develop COVID-19, which manifests across a wide spectrum of clinical severity ranging from mild upper respiratory tract illnesses to diffuse viral pneumonia, causing acute respiratory failure. Many therapies have been tested for their efficacy in treating COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basheer, Maamoun, Saad, Elias, Shlezinger, Dorin, Assy, Nimer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622396/ https://www.ncbi.nlm.nih.gov/pubmed/34822419 http://dx.doi.org/10.3390/metabo11110761

Ejemplares similares

Clinical Predictors of Mortality and Critical Illness in Patients with COVID-19 Pneumonia
por: Basheer, Maamoun, et al.
Publicado: (2021)

Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery
por: Basheer, Maamoun, et al.
Publicado: (2021)

Increased Red Blood Cell Distribution Predicts Severity of Chronic Obstructive Pulmonary Disease Exacerbation
por: Saad, Elias, et al.
Publicado: (2023)

Liver Fat Storage Is a Better Predictor of Coronary Artery Disease than Visceral Fat
por: Basheer, Maamoun, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
por: Bassal, Tamara, et al.
Publicado: (2022)

Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against?
por: Basheer, Maamoun, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients
por: Meerson, Ari, et al.
Publicado: (2019)

Effect of convalescent plasma therapy on mortality in moderate-to-severely Ill COVID-19 patients
por: Agrawal, Akanksha, et al.
Publicado: (2022)

The emergency use authorization for COVID‐19 convalescent plasma reduced mortality
por: Paneth, Nigel, et al.
Publicado: (2023)

Convalescent plasma in the management of COVID-19 pneumonia
por: Elbadawi, Ayman, et al.
Publicado: (2021)

COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients
por: Ibrahim, Moayed, et al.
Publicado: (2020)

Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
por: Salazar, Eric, et al.
Publicado: (2020)

Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
por: van den Berg, Karin, et al.
Publicado: (2022)

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
por: Maor, Yasmin, et al.
Publicado: (2020)

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
por: Simonovich, Ventura A., et al.
Publicado: (2020)

Success rate of Remdesivir, Convalescent Plasma, and Tocilizumab in moderate to severe Covid-19 pneumonia: our experience in a tertiary care center
por: Mohanty, Bijaya, et al.
Publicado: (2021)

The detrimental danger of water-pipe (Hookah) transcends the hazardous consequences of general health to the driving behavior
por: Elias, Wafa, et al.
Publicado: (2012)

Approach to Solid Liver Masses in the Cirrhotic Patient
por: Assy, Nimer, et al.
Publicado: (2009)

A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2022)

Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy
por: Semedi, Bambang Pujo, et al.
Publicado: (2022)

Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19
por: Fazeli, Alieh, et al.
Publicado: (2022)

Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19
por: Briggs, Neima, et al.
Publicado: (2021)

Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia
por: Romon, Iñigo, et al.
Publicado: (2021)

Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname
por: Bihariesingh-Sanchit, R., et al.
Publicado: (2023)

Risk factors for COVID-19 mortality: The effect of convalescent plasma administration
por: Salazar, Martín R., et al.
Publicado: (2021)

Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
por: Casadevall, Arturo, et al.
Publicado: (2021)

Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
por: Parikh, Purvish M., et al.
Publicado: (2021)

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
por: Rahimi-Levene, Naomi, et al.
Publicado: (2022)

Factors Affecting the Length of Convalescent Hospital Stay Following Total Hip and Knee Arthroplasty
por: Kuwakado, So, et al.
Publicado: (2021)

Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations
por: Park, Han-Sol, et al.
Publicado: (2023)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma
por: Einollahi, Behzad, et al.
Publicado: (2020)

Convalescent anti-SARS-CoV-2 plasma: Organising pneumonia: case report
Publicado: (2020)

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

CHIS/F06-Request for prior approval: expenses for cures/convalescence stays
por: Wanert-Calaga, Sophie Marie, et al.
Publicado: (2020)

Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia
por: Shankar, Ravi, et al.
Publicado: (2021)

Fulminant Klebssiella Pneumoniae Pneumonia in Immunocompetent Non Alcoholic Patient
por: Benyashvili, Z., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dsle8a71elruf5gfsjslem9ea2